BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
Institute for Medical Virology, University Hospital, Goethe University Frankfurt, 60596 Frankfurt am Main, Germany.
Sci Immunol. 2022 Sep 16;7(75):eabq2427. doi: 10.1126/sciimmunol.abq2427.
Omicron is the evolutionarily most distinct severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern (VOC) to date. We report that Omicron BA.1 breakthrough infection in BNT162b2-vaccinated individuals resulted in strong neutralizing activity against Omicron BA.1, BA.2, and previous SARS-CoV-2 VOCs but not against the Omicron sublineages BA.4 and BA.5. BA.1 breakthrough infection induced a robust recall response, primarily expanding memory B (B) cells against epitopes shared broadly among variants, rather than inducing BA.1-specific B cells. The vaccination-imprinted B cell pool had sufficient plasticity to be remodeled by heterologous SARS-CoV-2 spike glycoprotein exposure. Whereas selective amplification of B cells recognizing shared epitopes allows for effective neutralization of most variants that evade previously established immunity, susceptibility to escape by variants that acquire alterations at hitherto conserved sites may be heightened.
奥密克戎(Omicron)是迄今为止进化上最独特的严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)变体关注(VOC)。我们报告称,在接种了 BNT162b2 疫苗的个体中,奥密克戎 BA.1 突破感染导致对奥密克戎 BA.1、BA.2 和以前的 SARS-CoV-2 VOC 具有很强的中和活性,但对奥密克戎亚谱系 BA.4 和 BA.5 没有活性。BA.1 突破感染引起了强烈的回忆反应,主要是扩增了针对广泛存在于变异体中的表位的记忆 B(B)细胞,而不是诱导 BA.1 特异性 B 细胞。接种疫苗印记的 B 细胞库具有足够的可塑性,可以通过异源 SARS-CoV-2 刺突糖蛋白暴露进行重塑。虽然选择性扩增识别共享表位的 B 细胞可以有效中和大多数逃避先前建立的免疫的变体,但对获得迄今保守位点改变的变体的逃逸易感性可能会增加。